The Impact of Triglyceride-Glucose Index Trajectories on Incidence and Recurrent Cardiovascular Events: Evidence from
Yuan Xu1, Gonglong Wu2, Long Jiang3
1Medical Big Data Center, The Second Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.
Patients And Methods:
The study retrospectively collected 8086 clinical data from 2019 to 2021. Latent Class Trajectory Modeling (LCTM) was utilized to identify the longitudinal trajectories of the triglyceride-glucose index, and logistic regression was employed to analyze the relationship between different triglyceride-glucose trajectories and the incidence and recurrence of cardiovascular diseases.
Results:
During the study period, 1484 patients in the cohort experienced cardiovascular events. Using LCTM, three distinct triglyceride-glucose index trajectories were identified. In the overall cohort of recurrent patients, as well as among those with higher triglyceride-glucose levels (triglyceride-glucose > 8.309) within it, a high-gradual-increase trajectory was found to be significantly associated with cardiovascular disease risk compared to a low-stable trajectory. Similar observations were seen in incidence patients with higher triglyceride-glucose levels (OR 1.179; 95% CI 1.017-1.368), which adjusted the demographic characteristics and the test indicators.
Conclusion:
A high baseline level of triglyceride-glucose index with a high-gradual-increasing trajectory was significantly associated with incidence and recurrence of cardiovascular disease. Early identification of such populations can aid in the prevention of both incidence and recurrent cardiovascular diseases in the future.
Purpose:
The triglyceride-glucose index is related to the cerebrovascular diseases. This study aimed to investigate the relationship between different triglyceride-glucose index trajectories and incidence and recurrence of cardiovascular disease.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Glinides
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...


